Sign in

CIK 0001781174 · <br>Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
825125532
Phone
617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. ARS Other Annual Report to Security Holders
  13. DEFA14A Proxy Proxy Materials
  14. DEF 14A Proxy Proxy Statement
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. SCHEDULE 13D/A Stake Beneficial Ownership Report
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 8-K Event Results of operations · Regulation FD disclosure

Page 3 of 18 · 348 filings